Literature DB >> 19670417

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.

Andri Rauch1, Ian James, Katja Pfafferott, David Nolan, Paul Klenerman, Wendy Cheng, Lindsay Mollison, Geoff McCaughan, Nick Shackel, Gary P Jeffrey, Ross Baker, Elizabeth Freitas, Isla Humphreys, Hansjakob Furrer, Huldrych F Günthard, Bernard Hirschel, Simon Mallal, Mina John, Michaela Lucas, Eleanor Barnes, Silvana Gaudieri.   

Abstract

UNLABELLED: Many hepatitis C virus (HCV) infections worldwide are with the genotype 1 and 3 strains of the virus. Cellular immune responses are known to be important in the containment of HCV genotype 1 infection, and many genotype 1 T cell targets (epitopes) that are presented by host human leukocyte antigens (HLAs) have been identified. In contrast, there is almost no information known about the equivalent responses to genotype 3. Immune escape mechanisms used by HCV include the evolution of viral polymorphisms (adaptations) that abrogate this host-viral interaction. Evidence of HCV adaptation to HLA-restricted immune pressure on HCV can be observed at the population level as viral polymorphisms associated with specific HLA types. To evaluate the escape patterns of HCV genotypes 1 and 3, we assessed the associations between viral polymorphisms and specific HLA types from 187 individuals with genotype 1a and 136 individuals with genotype 3a infection. We identified 51 HLA-associated viral polymorphisms (32 for genotype 1a and 19 for genotype 3a). Of these putative viral adaptation sites, six fell within previously published epitopes. Only two HLA-associated viral polymorphisms were common to both genotypes. In the remaining sites with HLA-associated polymorphisms, there was either complete conservation or no significant HLA association with viral polymorphism in the alternative genotype. This study also highlights the diverse mechanisms by which viral evasion of immune responses may be achieved and the role of genotype variation in these processes.
CONCLUSION: There is little overlap in HLA-associated polymorphisms in the nonstructural proteins of HCV for the two genotypes, implying differences in the cellular immune pressures acting on these viruses and different escape profiles. These findings have implications for future therapeutic strategies to combat HCV infection, including vaccine design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19670417     DOI: 10.1002/hep.23101

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

1.  Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Authors:  Christopher P Desmond; Silvana Gaudieri; Ian R James; Katja Pfafferott; Abha Chopra; George K Lau; Jennifer Audsley; Caroline Day; Sarah Chivers; Adam Gordon; Peter A Revill; Scott Bowden; Anna Ayres; Paul V Desmond; Alexander J Thompson; Stuart K Roberts; Stephen A Locarnini; Simon A Mallal; Sharon R Lewin
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

3.  Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.

Authors:  Ahmed A Quadeer; Raymond H Y Louie; Karthik Shekhar; Arup K Chakraborty; I-Ming Hsing; Matthew R McKay
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

4.  Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.

Authors:  Jonathan M Carlson; Chanson J Brumme; Eric Martin; Jennifer Listgarten; Mark A Brockman; Anh Q Le; Celia K S Chui; Laura A Cotton; David J H F Knapp; Sharon A Riddler; Richard Haubrich; George Nelson; Nico Pfeifer; Charles E Deziel; David Heckerman; Richard Apps; Mary Carrington; Simon Mallal; P Richard Harrigan; Mina John; Zabrina L Brumme
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

5.  High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism.

Authors:  Marie-Eve Blais; Yonghong Zhang; Tim Rostron; Harry Griffin; Stephen Taylor; Keyi Xu; Huiping Yan; Hao Wu; Ian James; Mina John; Tao Dong; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

6.  Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.

Authors:  Shayarana L Gooneratne; Hamid Alinejad-Rokny; Diako Ebrahimi; Patrick S Bohn; Roger W Wiseman; David H O'Connor; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

7.  HLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors.

Authors:  Huaping Xiong; Jieting Huang; Xia Rong; Ming Zhang; Ke Huang; Ru Xu; Min Wang; Chengyao Li; Qiao Liao; Wenjie Xia; Guangping Luo; Xin Ye; Ling Lu; Yongshui Fu; Tai Guo; Kenrad Nelson
Journal:  Intervirology       Date:  2015-02-13       Impact factor: 1.763

8.  A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.

Authors:  Jason Gummow; Yanrui Li; Wenbo Yu; Tamsin Garrod; Danushka Wijesundara; Amelia J Brennan; Ranajoy Mullick; Ilia Voskoboinik; Branka Grubor-Bauk; Eric J Gowans
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

9.  Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak.

Authors:  Shahzma Merani; Danijela Petrovic; Ian James; Abha Chopra; Don Cooper; Elizabeth Freitas; Andri Rauch; Julia di Iulio; Mina John; Michaela Lucas; Karen Fitzmaurice; Susan McKiernan; Suzanne Norris; Dermot Kelleher; Paul Klenerman; Silvana Gaudieri
Journal:  Hepatology       Date:  2011-01-18       Impact factor: 17.425

10.  Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.

Authors:  Stefania Capone; Mariarosaria Naddeo; Anna Morena D'Alise; Adele Abbate; Fabiana Grazioli; Annunziata Del Gaudio; Mariarosaria Del Sorbo; Maria Luisa Esposito; Virginia Ammendola; Gemma Perretta; Alessandra Taglioni; Stefano Colloca; Alfredo Nicosia; Riccardo Cortese; Antonella Folgori
Journal:  Mol Ther       Date:  2014-01-30       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.